Stomach Neoplasms: all 2,914 studies
Page 21 of 30. Open to participants first (880), then studies with results posted, then the rest; newest registration first within each.
- Real-time Activity Monitoring to Prevent Admissions During RadioTherapyCompletedNCT03102229Not applicable
- Molecular Analysis in Peritoneal Washing Citology for Locally Advanced Gastric CancerStatus unknownNCT03098758
- A Phase I Study of High Dose Simvastatin in Patients With Gastrointestinal Tract Cancer Who Failed to Standard ChemotherapyStatus unknownNCT03086291Phase 1
- Raltitrexed and Paclitaxel for Gastric or Gastroesophageal Junction AdenocarcinomaCompletedNCT03083613Phase 2
- Phase II Trial of AZD2014 in TSC1/2 Mutated or TSC1/2 Null GC Patients as Second-line ChemotherapyTerminatedNCT03082833Phase 2
- ERAS (Early Recovery After Surgery) Protocol After Laparoscopic Total Gastrectomy and Proximal GastrectomyStatus unknownNCT03079596Not applicable
- Discovery and Validation of Plasma DNA Methylation Biomarker for Detection of Stomach CancerCompletedNCT03076567
- A Study Evaluating MM-310 in Patients With Solid TumorsStatus unknownNCT03076372Phase 1
- The Origin of Infrapyloric ArteryCompletedNCT03071237
- FOLFIRI Versus Docetaxel and Cisplatin as a Second-line Chemotherapy After Failure of First-line Chemotherapy in Advanced Gastric CancerCompletedNCT03067792Phase 3
- Nutritional Safety and Metabolic Benefits of Oncometabolic Surgery for Obese Gastric Cancer PatientsCompletedNCT03067012Not applicable
- Effect of H. Pylori Eradication on the Fate of H. Pylori-associated Gastric PolypCompletedNCT03065868Phase 4
- Endoscopic Resection Multicenter RegistryStatus unknownNCT03065257
- Trial of Single Agent AZD2014 in RICTOR Amplified GC Patients as Second-line TherapyTerminatedNCT03061708Phase 2
- Sarcopenia and Visceral Obesity in Esophageal and Gastric CancerCompletedNCT03061370
- Pulsed Low Dose Rate Radiation Therapy for Gastric Cancer Patients With Peritoneal MetastasisStatus unknownNCT03061162Not applicable
- Individualized Intraperitoneal and System Chemotherapy Versus System Chemotherapy as First-line Chemotherapy for AGCStatus unknownNCT03061058Phase 3
- A Study on the Gastrointestinal Disease and Helicobacter Pylori Controlled Long Non-coding RNAStatus unknownNCT03057171
- Study of Vismodegib in Advanced Gastric Adenocarcinoma Patients With SMO OverexpressionCompletedNCT03052478Phase 2
- Indocyanine Green Tracer Using in Laparoscopic Gastrectomy With Lymph Node DissectionCompletedNCT03050879Phase 2
- Gastric Cancer Sentinel Lymph Node MappingStatus unknownNCT03049345Not applicable
- Gastric Cancer Registry for Epidemiology and Molecular Risk FactorStatus unknownNCT03046745
- mFOLFOX Versus mFOLFIRI Versus FOLFPTX as First-line Treatment in AGC or EGJAStatus unknownNCT03045770Not applicable
- PD-1 Knockout EBV-CTLs for Advanced Stage Epstein-Barr Virus (EBV) Associated MalignanciesStatus unknownNCT03044743Phase 1/2
- Nivolumab +/- Relatlimab Prior to Chemoradiation With II/III Gastro/Esophageal CancerActive, not recruitingNCT03044613Phase 1
- Enhanced Recovery After Surgery(ERAS) for Gastric Cancer and Perioperative Nutritional StatusStatus unknownNCT03043183Not applicable
- Surgical Resection Plus Chemotherapy Versus Chemotherapy Alone in Oligometastatic Stage IV Gastric CancerTerminatedNCT03042169Phase 3
- Clinical Trial to Compare Apatinib Plus Irinotecan Versus Single Irinotecan as Second-line Treatment in AGC or EGJAStatus unknownNCT03030937Phase 2
- Hereditary Gastric Cancer Syndromes: An Integrated Genomic and Clinicopathologic Study of the Predisposition to Gastric CancerCompletedNCT03030404
- Prospective Evaluation and Molecular Profiling in People With Gastric TumorsCompletedNCT03027427
- A Study of Fluzoparib Given in Combination With Apatinib and Paclitaxel in Gastric Cancer PatientsStatus unknownNCT03026881Phase 1
- Efficacy and Safety of Hou Gu Mi Xi in Patients With Spleen Qi Deficiency and Radical Gastrectomy for Gastric CancerTerminatedNCT03025152Not applicable
- Cytoreductive Surgery Combined With HIPEC and Chemotherapy for Gastric Cancer With Peritoneal MetastasisStatus unknownNCT03023436Phase 3
- Lanreotide and Octreotide Long Acting Release (LAR) for Patients With Advanced Gastroenteropancreatic Neuroendocrine Tumors (GEP-NETs)CompletedNCT03017690
- Enhanced Recovery After Surgery (ERAS) on Laparoscopy-assisted Distal GastrectomyStatus unknownNCT03016026Phase 2
- IV Ascorbic Acid in Advanced Gastric CancerStatus unknownNCT03015675Phase 3
- Comparing the Diagnostic Role of PET/MRI and of PET/CT Among Patients With Gastric CancerStatus unknownNCT03015298
- PREACT Study: Locally Advanced Gastric Cancer, Chemoradiotherapy vs. Chemotherapy Followed by D2 Surgery and Adjuvant ChemotherapyCompletedNCT03013010Phase 3
- Study On Safety Of Laparoscopic Total Gastrectomy For Clinical Stage I Gastric CancerCompletedNCT03007550Not applicable
- The Study of Conversion Surgery for Apatinib in Combination With SOX for Patients With Unresectable Gastric CancerStatus unknownNCT03007446Phase 2
- Study of Adjuvant ONO-4538 With Resected Gastric CancerCompletedNCT03006705Phase 3
- PHASE III RANDOMISED TRIAL to EVALUATE FOLFOX with or WITHOUT DOCETAXEL (TFOX) AS 1st LINE CHEMOTHERAPY for LOCALLY ADVANCED or METASTATIC OESOPHAGO-GASTRIC CARCINOMACompletedNCT03006432Phase 3
- Randomized Controlled Trials on Clinical Outcomes of Totally Laparoscopic Versus Laparoscopy Assisted Total Gastrectomy for Gastric CancerStatus unknownNCT03006263Not applicable
- To Observe the Efficacy and Safety by Comparing Chemotherapy(Docetaxel, Oxaliplatin Plus S1 ) Followed With Radical Resection Versus Chemotherapy Alone in Advanced Gastric Cancer With Single Non-curable Factor.Status unknownNCT03001726
- A Phase 1/2 Study of Ramucirumab Plus Nivolumab in Participants With Gastric or GEJ CancerCompletedNCT02999295Phase 1/2
- A Phase Ib/II Study of Efficacy and Feasibility of Cytoreductive Surgery, Extensive Peritoneal Lavage, Hyperthermicintraperitoneal Chemotherapy and Post-operative Intraperitoneal Chemotherapy Combination in Gastric Cancer With Peritoneal MetastasisCompletedNCT02995850Phase 1/2
- Laparoscopic Versus Open Gastrectomy With Splenic Hilum Lymph Nodes DissectionStatus unknownNCT02980861Phase 3
- The Efficacy of Surgical Treatment After Neoadjuvant Chemotherapy Plus Intraperitoneal Immunotherapy Versus Chemotherapy Alone for Patients With Positive Wash Cytology Gastric CancerStatus unknownNCT02976142Phase 2
- Laparoscopic Bursectomy and D2 Lymphadenectomy vs.Laparoscopic D2 Lymphadenectomy in Advanced Gastric CancerStatus unknownNCT02969148Not applicable
- Treatment Strategy for Stage IV Gastric Cancer with Positive Peritoneal Cytology As the Only Non-curable FactorTerminatedNCT02969122Not applicable
- Mucolytic Solution Before Upper EndoscopyStatus unknownNCT02967094Not applicable
- Perioperative Chemotherapy Combined With HIPEC for High-risk Advanced Gastric CancerStatus unknownNCT02960061Phase 3
- Biomarker-Integrated Umbrella, Advanced Gastric CancerCompletedNCT02951091Not applicable
- Neoadjuvant Chemotherapy With SEEOX Regimen for Borrmann Type 4 Gastric CancerStatus unknownNCT02949258Phase 2
- Association Between Mitochondrial DNA Content and Risk of Gastric CancerCompletedNCT02944539
- A Study of Perioperative mFOLFOX6 Plus Pembrolizumab in Patients With Potentially Resectable Adenocarcinoma of the Gastroesophageal Junction (GEJ) and StomachWithdrawnNCT02943603Phase 2
- Exploratory Clinical Study of Apatinib and SHR-1210 in Treating Advanced Hepatocellular Carcinoma or Gastric CancerStatus unknownNCT02942329Phase 1/2
- Laparoscopy-assisted Pylorus-vagus Nerve Preserving Gastrectomy in the Treatment of Early Gastric CancerStatus unknownNCT02936193Not applicable
- Assessment of Ramucirumab Plus Paclitaxel as Switch MANteInance Versus Continuation of First-line Chemotherapy in Patients With Advanced HER-2 Negative Gastric or Gastroesophageal Junction CancersStatus unknownNCT02934464Phase 3
- Multicentric Randomised Trial for Resectable Gastric CancerActive, not recruitingNCT02931890Phase 2
- The Effect of Preoperative Inflammation-based Scores on Postoperative Morbidity and Mortality for Laparoscopic GastrectomyStatus unknownNCT02930291
- The Effect of Preoperative Hemotologic Markers on Postoperative Long-term and Short-term Outcomes for Laparoscopic GastrectomyStatus unknownNCT02930278
- NBI for Identifying Resection Margin Status in Gastric CancerCompletedNCT02926716
- Modified Wet Suction Versus Capillary Techniques for EUS Guided Fine Needle Aspiration and Biopsy of Solid LesionsWithdrawnNCT02919553Not applicable
- The Maintenance Treatment of UFT in Advanced Gastric CancerCompletedNCT02903498Phase 2
- The Safety and Feasibility of Laparoscopic-assisted Gastrectomy for Advanced Gastric Cancer After Neoadjuvant ChemotherapyCompletedNCT02902575Not applicable
- Pembrolizumab, Trastuzumab, HER2 Positive Gastric CancerStatus unknownNCT02901301Phase 1/2
- CureOne Registry: Advanced Malignancy or Myelodysplasia, Tested by Standard Sequencing and Treated by Physician ChoiceTerminatedNCT02900248
- Comparison of Laparoscopic Proximal Gastrectomy and Laparoscopic Total GastrectomyCompletedNCT02892643Not applicable
- A Study DHP107, a Novel Oral Paclitaxel Formulation, in Patients With Advanced Solid Tumours or Gastric CancerCompletedNCT02890511Phase 1/2
- ctDNA for Prediction of Relapse in Gastric CancerStatus unknownNCT02887612
- Precision Cell Immunotherapy Combined With Chemotherapy in Advanced Gastric CancerStatus unknownNCT02873520Phase 1/2
- Adjuvant Chemotherapy With S-1 Plus Oxaliplatin Versus S-1 Alone in Locally Advanced Gastric CancerTerminatedNCT02867839Phase 3
- Metronomic Chemotherapy in Advanced Gastric CancerStatus unknownNCT02855788Phase 2
- Quality-Of-Life QLQ-GINET21 Questionnaire In The Treatment Of Patients With Gastrointestinal Neuroendocrine TumoursCompletedNCT02853422
- Assessing Her2/Neu Expression in Gastric Cancer With Dual or Multiple Tumor Tissue Paraffin BlocksStatus unknownNCT02852096Not applicable
- Glycans Bound to Serum Haptoglobin: a Novel Gastric Cancer Tumor BiomarkerCompletedNCT02848066
- Study on Laparoscopic Spleen-Preserving No. 10 Lymph Node Dissection for Advanced Gastric CancerStatus unknownNCT02845986Phase 2
- POF Versus FOLFOX Versus FOLFOX Plus ip Paclitaxel in AGCCompletedNCT02845908Phase 2
- The Thoracic Peri-Operative Integrative Surgical Care Evaluation (POISE) Trial- Stage ICompletedNCT02845479Phase 3
- The Clinical Study of Assessing HER-2 Expression in Gastric Cancer With Extra Tumor Tissue Paraffin Blocks Using ImmunohistochemistryStatus unknownNCT02843412
- CAR-pNK Cell Immunotherapy in MUC1 Positive Relapsed or Refractory Solid TumorStatus unknownNCT02839954Phase 1/2
- Comparisons Between Isoperistaltic and Antiperistaltic Gastrojejunostomy in Laparoscopic Distal GastrectomyStatus unknownNCT02837874Not applicable
- Difference of Gastric Microbiota in the Process of Correa's Model.Status unknownNCT02833363
- A Efficacy and Tolerability Study of TEGAFOX Sequential S-1 in the Treatment of Adjuvant Chemotherapy for Gastric CancerStatus unknownNCT02817425Phase 2/3
- Safety of 250ml Preoperative Carbohydrate Drink in Gastric Cancer PatientsCompletedNCT02815150Not applicable
- Comparison of Vagus Nerve-preserving RADG and Conventional RADG for AGCStatus unknownNCT02806661Not applicable
- Combination Trastuzumab With Expanded Natural Killer Cells for Treating HER2-positive Gastric CancerStatus unknownNCT02805829Phase 1/2
- Effect of Obesity on Surgical Outcomes and Survival for Gastric CancerStatus unknownNCT02800005Not applicable
- Role of Probe-based Confocal Laser Endomicroscopy Targeted Biopsy in the Molecular Study of Undifferentiated Gastric CancerCompletedNCT02799420Not applicable
- Randomized Controlled Trials on Laparoscopic No. 14v LNS DissectionStatus unknownNCT02789891Not applicable
- Laparoscopic Versus Open Resection of Cancer StomachCompletedNCT02789826Not applicable
- Quality of Life, Treatment Experience and Cost of Treatment With Somatostatin Analogues in Patients With Gastroenteropancreatic Neuroendocrine TumoursCompletedNCT02788565
- Helicobacter Pylori Genome Project (HpGP)TerminatedNCT02788214
- Study of Gastroduodenal Metallic Stent vs GastrojejunostomyStatus unknownNCT02784470Phase 3
- Effect of Prehabilitation in Gastroesophageal Adenocarcinoma: Study Protocol of a Multicentric, Randomised Control TrialStatus unknownNCT02780921Phase 3
- The Study of Intraperitoneal Docetaxel Plus S-1 for Malignant AscitesStatus unknownNCT02779608Phase 2
- Prophylactic or Preemptive Entecavir in Patients With Gastric Cancer Who Are Inactive Hepatitis B CarriersStatus unknownNCT02777801Phase 2
- A Clinical Trial of Maintenance Treatment of Apatinib in Advanced Gastric Cancer Patients Have Completed Postoprative Adjuvant ChemotherapyStatus unknownNCT02776527Phase 4
- Endoscopic Full Thickness Resection Without Exposure to PeritoneumStatus unknownNCT02764944Phase 1